GOLDEN ARTHUR F
SEC Form 4 insider trading activity
GOLDEN ARTHUR F has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Apr 3, 2026.
On the most recent filing, GOLDEN ARTHUR F is listed as Director at Turn Therapeutics Inc. Inside the rolling window, GOLDEN ARTHUR F reported 2 open-market purchases totaling $159K in TTRX and no open-market sales. The largest disclosed transaction in the window is a purchase of 20,202 TTRX shares on Oct 23, 2025, worth $100K.
Companies traded
Other insiders at TTRX
Insider Buying
$159K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GOLDEN ARTHUR F made?
GOLDEN ARTHUR F has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does GOLDEN ARTHUR F trade?
GOLDEN ARTHUR F has filed SEC Form 4 disclosures for 1 company, including TTRX.
When was GOLDEN ARTHUR F's most recent SEC Form 4 filing?
GOLDEN ARTHUR F's most recent SEC Form 4 filing on Tracefour is dated Apr 3, 2026.
What is GOLDEN ARTHUR F's total buy and sell value in the current window?
Inside the rolling retention window, GOLDEN ARTHUR F bought $159K and sold $0 based on SEC Form 4 filings.
What was GOLDEN ARTHUR F's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 20,202 TTRX shares on 2025-10-23, worth $100K, per SEC Form 4 filings.